主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PRTC
#3035
PureTech Health plc American Depositary Shares
17.8
7
USD
+0.34%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+0.34%
每月变动
+9.03%
6个月变化
-1.65%
年变化
+6.75%
前一天收盘价
17.8
1
开盘价
17.8
7
买价
卖价
最低价
17.8
7
High
17.8
7
交易量
1
市场
股票
医疗保健
PRTC
展开完整图表
Financials
概览
声明
统计
每季度
年度
Market Capitalization
427.85 M
Employee
90
Founded
2005
CEO
Robert Lyne
Website
www.puretechhealth.com
Headquarter
United Kingdom
FIGI
BBG00Y6FM4S2
Industry
Technology
总收入
净利润
总债务
自由现金流
现金及现金等价物
总收入
4.83 M
427.85 M
市值
净利润
27.78 M
PureTech Health plc - American Depositary Shares
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
新闻
Deupirfenidone获得罕见肺病孤儿药资格
Deupirfenidone receives orphan drug status for rare lung disease
PureTech的deupirfenidone获得FDA和欧盟治疗特发性肺纤维化孤儿药资格
PureTech’s deupirfenidone receives FDA and EU orphan drug status for IPF
PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
PureTech CEO to present at J.P. Morgan Healthcare Conference
PureTech Health任命Robert Lyne为永久首席执行官
PureTech Health appoints Robert Lyne as permanent CEO
PureTech在股东担忧后提供股东大会结果更新
PureTech provides update on AGM results following shareholder concerns
PureTech股价在FDA关于IPF药物会议后下跌
PureTech stock falls after FDA meeting on IPF drug